NCT03067688View on ClinicalTrials.gov

Clinical Trial of Temisartan/Amlodipine & Rosuvastatin in Subjects With Hypertension and Hyperlipidemia

PHASE3CompletedINTERVENTIONAL

Enrollment

202

Participants

Timeline

Start Date

April 11, 2017

Primary Completion Date

March 27, 2018

Study Completion Date

March 27, 2018

Conditions

HypertensionHyperlipidemia

Interventions

DRUG

Temisartan+Amlodipine+Rosuvastatin (Combination drug)

PO, Once daily(QD), 8weeks

DRUG

Temisartan+Amlodipine

PO, Once daily(QD), 8weeks

DRUG

Temisartan+Rosuvastatin

PO, Once daily(QD), 8weeks

Trial Locations (1)

03080

Seoul Natuional University Hospital, Seoul

All Listed Sponsors

lead

Yuhan Corporation

INDUSTRY

NCT03067688 - Clinical Trial of Temisartan/Amlodipine & Rosuvastatin in Subjects With Hypertension and Hyperlipidemia | Biotech Hunter | Biotech Hunter